Kenya Hepatitis Market Analysis

$3,000.00$7,500.00

  • Type: Therapeutics Area
  • Published : June 2021
  • Region: Africa
  • Country: Kenya
  • Report ID : 4821

  • Format: PPT, PDF

Kenya Hepatitis Drug Market: Segmented by Disease types (Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D and Others), Drug Class (Interferon, Monoclonal Antibody, Non-structural protein 5A (NS5A) inhibitors, Nucleotide Analog Reverse Transcriptase Inhibitors, Nucleotide Analog NS5B Polymerase Inhibitors, Multi Class Combination, and Other Drug Classes), and Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others) – Growth, Trends, and Forecasts (2019 – 2028)

Clear
SKU: 4821 Categories: ,

Report Overview

The Hepatitis Drug market size in Kenya stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Hepatis is an inflammatory condition of liver commonly caused by a viral infection or due to certain medications or excessive alcohol consumption. There are five strains of hepatitis viruses namely Hepatitis A, B, C, D, or E Virus. Hepatitis can be short term (Hepatis A) or can cause chronic illness (Hepatitis B and C). Untreated chronic hepatitis B infection can result in liver cirrhosis and eventually death. Health care workers, intravenous drug users, commercial sex workers and men who have sex with men (MSM) are high risk groups for Hepatitis B virus (HBV) infection. Due to similar routes of transmission, Human Immunodeficiency Virus (HIV) infected individuals are also at high risk for Hepatitis B infection. The prevalence of HBV infection in Kenya is estimated to be between 1% to 5%, although rates among specific high-risk populations (HIV co-infected, drug abusers, jaundiced patients seeking medical care) are much higher. There is high Hepatitis C (HCV) infection prevalence among cohort of drug users (22.2%) as compared to that of the general population, which is estimated to be 0.2-0.9%.

Market Drivers

The market is majorly driven by the high prevalence rate of Hepatitis B infection in Kenya. The risk of Hepatitis B infection is greatly increased due to the high prevalence of HIV/AIDs in Kenya as HIV and HBV share common mode of transmissions.

Increase in substance abuse, alcohol consumption, involving in unprotected sex and other risk factors among adolescents in Kenya are leading to high incidence of HBV infections.

Increase in Government initiatives like screening for hepatitis among high-risk populations and providing clinical care for patients who have tested positive is expected to fuel growth in the hepatitis drug market.

However, the side effects caused by several Drug are restraining market growth. The outbreak of COVID-19 has decreased diagnosis, screening and follow-up of patients suffering from hepatitis which has negative outcomes of health in patients with hepatis.

1. Kenya Hepatitis Drug Market Overview…………………………..…………………
A. Market Size
2. Market Growth Drivers………………………………………………………..…….
A. High Prevalence of Viral Hepatitis
B. Increase in the Risk Factors Associated with Hepatitis
C. Increase in Government Support for Screening and Clinical Care
3. Major Hepatitis Types……………………………………………………………………………….
A. Hepatitis A
B. Hepatitis B
C. Hepatitis C
D. Hepatitis D
E. Hepatitis E
F. Others
4. Hepatitis Drug Market Segmentation……………………………………………………
A. Drug Class
I. Interferon
II. Monoclonal Antibody
III. Non-structural protein 5A (NS5A) inhibitors
IV. Nucleotide Analog Reverse Transcriptase Inhibitors
V. Nucleotide Analog NS5B Polymerase Inhibitors
VI. Multi Class Combination
VII. Others
B. Distribution Channels
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online Pharmacies
IV. Others
5. Hepatitis Major Products Market Share…………………………………….…
A. Key Findings
B. Market Analysis, Insights and Forecast – By Drug Type
6. Competitive Landscape………………………………………………………..……
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………..…..
A. Merck & Co. Company overview, Product & Services, Strategies & Financials
B. Johnson & Johnson Company overview, Product & Services, Strategies & Financials
C. Novartis Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………….………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………………
A. New Trends and Development of Hepatitis drug market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Disease type:

On the basis of disease type hepatitis drug market can be segmented into Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D and Hepatitis E.

Hepatitis B and C are the most prevalent and chronic types of hepatitis.

By Drug Class:

On the basis of drug class, Kenya Hepatitis Drug market can be segmented into Interferon, Monoclonal Antibody, Non-structural protein 5A (NS5A) inhibitors, Nucleotide Analog Reverse Transcriptase Inhibitors, Nucleotide Analog NS5B Polymerase Inhibitors, Multi Class Combination, Other Drug Classes.

By Distribution Channels:

On the basis of distribution channels, the hepatitis drug market in Kenya can be segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and others.

 Major Players

Some of the leading market players include Merck & Co., Inc, GlaxoSmithKline (GSK), Johnson & Johnson, Novartis AG, Bristol Myers Squibb Company, Merck & Co.  and F. Hoffmann-La Roche, Ltd.

GlaxoSmithKline is leading in the hepatitis vaccine market in Kenya with its Twinrix vaccine which is a combination of hepatitis A (Inactivated) and hepatitis B (Recombinant).

GlaxoSmithKline is also leading in the Drug segment(Anti-viral) in Kenya for treatment of Hepatitis Infection with Valtrex and Tivicay followed by Johnson & Johnson.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements